Arcus Biosciences, Inc. (RCUS)
23.92
+0.18
(+0.74%)
USD |
NYSE |
May 21, 16:00
23.92
0.00 (0.00%)
After-Hours: 19:59
Arcus Biosciences EPS Diluted (Quarterly) : -1.021 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.612 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.00M |
| Revenue (Quarterly) | 17.00M |
| Total Expenses (Quarterly) | 145.00M |
| Enterprise Value | 2.277B |
| Gross Profit Margin (Quarterly) | 88.24% |
| Profit Margin (Quarterly) | -752.9% |
| Earnings Yield | -13.31% |
| Normalized Earnings Yield | -13.31 |